Effects of a Five-Dimensional Intervention Program Based on Inner Strength on Demoralization Syndrome in Elderly Cancer Patients
2026年5月29日 更新者:Peking Union Medical College Hospital
From January 2025 to January 2026, a total of 66 elderly cancer patients with demoralization syndrome who were hospitalized in the Department of Internal Medicine at Peking Union Medical College Hospital were enrolled.
Participants were allocated randomly to either a control group (CG, n = 33) or an intervention group (IG, n = 33) utilizing a random number table in combination with the ward-floor allocation method.
The CG received routine oncology nursing care, whereas the IG received a one-month, five-dimensional intervention program based on inner strength in addition to standard care.
Outcomes were assessed utilizing the Chinese versions of Demoralization Scale, Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), Inner Strength Scale, and Self-Efficacy Scale.
研究概览
研究类型
介入性
注册 (实际的)
66
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Beijing、中国、100076
- Peking Union Medical College Hospital
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
是的
描述
Inclusion Criteria:
- Age ≥ 60 years
- Diagnosis of a malignant tumor confirmed by pathological biopsy or imaging, in accordance with the Diagnosis and Treatment Specifications for Malignant Tumors
- Fulfillment of the diagnostic criteria for demoralization syndrome, described as a score > 30 on the Chinese version of the Demoralization Scale (DS)
- Clear consciousness, with the capability to communicate effectively or complete questionnaires, and no evidence of cognitive impairment
- Voluntary participation with signed informed consent
- Expected survival ≥ 3 months, without vital organs' severe dysfunction, including the liver, kidneys, or heart
Exclusion Criteria:
- Presence of psychiatric disorders, severe cognitive impairment, aphasia, or other conditions that would interfere with participation in the intervention or assessments
- Severe complications, cachexia, or rapidly progressing disease
- Receipt of psychological interventions or psychotropic medications within the previous month
- Transfer to another hospital, withdrawal from the study, or loss to follow-up during the study period
- A history of alcohol or drug dependence
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
其他:Inner strength; Elderly; Cancer; Demoralization syndrome
psychological support
|
From January 2025 to January 2026, a total of 66 elderly cancer patients with demoralization syndrome who were hospitalized in the Department of Internal Medicine at our hospital were enrolled.
Participants were allocated randomly to either a control group (CG, n = 33) or an intervention group (IG, n = 33) utilizing a random number table in combination with the ward-floor allocation method.
The CG received routine oncology nursing care, whereas the IG received a one-month, five-dimensional intervention program based on inner strength in addition to standard care.
Outcomes were assessed utilizing the Chinese versions of Demoralization Scale, Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), Inner Strength Scale, and Self-Efficacy Scale.
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Chinese version of the Disappointment Scale
大体时间:one month
|
one month
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
self-rating anxiety scale
大体时间:one month
|
one month
|
|
Depression Self-Rating Scale
大体时间:one month
|
one month
|
|
Chinese Version of the Inner Strength Scale
大体时间:one month
|
one month
|
|
Self-Efficacy Scale
大体时间:one month
|
one month
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2025年7月4日
初级完成 (实际的)
2025年12月12日
研究完成 (实际的)
2025年12月12日
研究注册日期
首次提交
2026年5月7日
首先提交符合 QC 标准的
2026年5月29日
首次发布 (实际的)
2026年6月4日
研究记录更新
最后更新发布 (实际的)
2026年6月4日
上次提交的符合 QC 标准的更新
2026年5月29日
最后验证
2026年4月1日
更多信息
与本研究相关的术语
其他研究编号
- K7564
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.